The U.S. IVF services market was valued at $2,213.1 million in 2015, and is estimated to reach $4,472.2 million by 2022, registering a CAGR of 10.6% from 2016 to 2022. Fresh IVF cycles (non-donor) segment held more than one-third share of the total market in 2015. Rise in incidence of late parenthood and decrease in total fertility rate drive the growth of the market. In addition, increase in popularity of IVF technique that helps one conceive propels market growth.
Download Report Sample: https://www.alliedmarketresearch.com/request-sample/3491
In vitro fertilization is a type of assisted reproductive technology, which involves the artificial fertilization of egg with sperm in laboratory settings and then resulting zygote is implanted into the uterus. According to the Society for Assisted Reproductive Technology (SART), in 2013 about 1.5% babies born in the U.S. were conceived through IVF procedures
Delay in parenthood, increase in number of infertility cases due to age concern, and increase in trend of middle age pregnancies drive the market. In addition, rise in health awareness on fertility issues, adoption of advanced IVF procedures, and increase in consumption of alcohol and cigarettes leading to sedentary lifestyles further fuel the market growth. However, factor such as expensive IVF treatments and stringent government regulations restrain the market growth. The upsurge in demand for novel IVF technologies and rise in disposable incomes are expected to provide numerous opportunities for market growth during the forecast period.
The overall number of embryo transfers performed in U.S. stood at 180.4 thousand in 2015 and is expected to reach 353.7 thousand by 2022, registering a CAGR of 10.1% during the forecast period. The growth of the market is associated with modern lifestyle, increase in infertility rate among couples, availability of advanced technology, and skilled IVF technicians.
The fertility clinics segment is anticipated dominate the market during the forecast period in terms of volume and revenue. This is due to the reason that fertility clinics provide technologically advanced and wide range of fertility treatments under one roof for patients.
Get More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/3491
Key Findings of the U.S. IVF Services Market:
• Based on cycle type, in 2015, fresh IVF cycle (non-donor) segment accounted for around half share of the total market, in terms of revenue and volume.
• Based on end user, clinical research institutes segment is projected to be one of the fastest growing segment at a CAGR of 11.1% in terms of revenue.
• Based on end user, in 2015, fertility clinics segment accounted for around three-fifths share of the total market in terms of volume.
Key players in the U.S. IVF services market includes companies, hospitals, surgical centers, fertility centers, and clinical research institutes. These are Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey.
TABLES OF CONTENT
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDING OF THE STUDY
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW
3.3. MARKET SIZE AND FORECAST
3.3.1. Number of infertility clinics, 2015
3.4. REGULATORY ISSUES, LEGISLATIONS, AND AUTHORITIES
3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. KEY IMPACTING FACTORS
3.6.1. Drivers
3.6.1.1. Increasing popularity of IVF in the U.S.
3.6.1.2. Increased rate of infertility and practices of embryo banking cycles
3.6.1.3. Delayed pregnancy
3.6.1.4. Technological advancements in IVF treatment
3.6.2. Restraints
3.6.2.1. High cost of IVF treatments in the U.S.
3.6.2.2. Restrictions on three-parent IVF treatments
3.6.2.3. Scattered Reimbursements
Access Full Summery @ https://www.alliedmarketresearch.com/US-IVF-services-market